--- title: "The chemical pharmaceutical sector continues to rise, with SUNHERE and Lionco hitting the daily limit" type: "News" locale: "en" url: "https://longbridge.com/en/news/246756484.md" description: "The chemical pharmaceutical sector continues to rise, with SUNHERE and Lionco hitting the daily limit, while Beilu Pharmaceutical, Hanyu Pharmaceutical, Yong'an Pharmaceutical, Xinghao Pharmaceutical, and Hasenlian also follow suit" datetime: "2025-07-01T01:51:31.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/246756484.md) - [en](https://longbridge.com/en/news/246756484.md) - [zh-HK](https://longbridge.com/zh-HK/news/246756484.md) generator: "portal-rs" --- # The chemical pharmaceutical sector continues to rise, with SUNHERE and Lionco hitting the daily limit The chemical pharmaceutical sector continues to rise, with SUNHERE and Lionco hitting the daily limit, while Beilu Pharmaceutical, Hanyu Pharmaceutical, Yong'an Pharmaceutical, Xinghao Pharmaceutical, and Ha Sanlian also saw gains ### Related Stocks - [603669.CN](https://longbridge.com/en/quote/603669.CN.md) - [300452.CN](https://longbridge.com/en/quote/300452.CN.md) - [300016.CN](https://longbridge.com/en/quote/300016.CN.md) - [300199.CN](https://longbridge.com/en/quote/300199.CN.md) - [002365.CN](https://longbridge.com/en/quote/002365.CN.md) - [002900.CN](https://longbridge.com/en/quote/002900.CN.md) ## Related News & Research - [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md) - [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md) - [HENGRUI PHARMA 1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md) - [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md) - [REG - American Century Inv Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group plc](https://longbridge.com/en/news/296624941.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**